source Post navigation A deprescribing programme aimed to optimise blood glucose-lowering medication in older people with type 2 diabetes mellitus, the OMED2-study: the study protocol for a randomised controlled trial – Trials Journal The FDA chief is right: we are failing people with diabetes – The Guardian